Institution: | 1. NGM Biopharmaceuticals, South San Francisco, CA 94080, USA;2. Department of Antibody Discovery & Protein Engineering, MedImmune Ltd, Cambridge CB21 6GH, UK;3. Department of Cardiovascular and Metabolic Disease Research, MedImmune LLC, Gaithersburg, MD 20878, USA |